BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 16, 2025
See today's BioWorld Asia
Home
» First repurposing trial for COVID-19 falls flat
To read the full story,
subscribe
or
sign in
.
Testing, testing
First repurposing trial for COVID-19 falls flat
March 24, 2020
By
Anette Breindl
No Comments
The first attempt at using existing drugs to treat patients infected with SARS-CoV-2 has yielded disappointing results.
BioWorld Asia
Clinical